Stock comparison
Eli Lilly
Veeva Systems
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LLY
Eli Lilly
Market cap
$1T
Sector
Healthcare
VEEV
Veeva Systems
Market cap
$26.07B
Sector
Healthcare
Overall winner
Eli Lilly LLY
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LLY | VEEV | Winner |
|---|---|---|---|
| Warren Buffett | 72B | 66B | LLY |
| Benjamin Graham | 86A | 81A | LLY |
| Philip Fisher | 86A | 77B | LLY |
| Peter Lynch | 74B | 60C | LLY |
| Joel Greenblatt | 78C | 52C | LLY |
| Charlie Munger | 85A | 62C | LLY |
| Terry Smith | 77C | 65D | LLY |
Side-by-side metrics
| Metric | LLY | VEEV |
|---|---|---|
| Market cap | $1T | $26.07B |
| P/E (TTM) | 36.6x | 28.7x |
| EV/EBIT | 34.1x | 26.9x |
| ROIC (TTM) | 32.06% | 9.48% |
| Gross margin | 83.51% | 75.53% |
| Net margin | 34.98% | 28.44% |
| Revenue CAGR 5y | 23.17% | 14.63% |
| EPS CAGR 5y | 40.81% | 18.76% |
| Debt / Equity | 1.4x | 0.0x |
| Dividend yield | 0.62% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LLY leads on
- Dividend yield0.62%vs 0.0%+100%
- Market cap$1Tvs $26.07B+97%
- ROIC (TTM)32.06%vs 9.48%+70%
- EPS CAGR 5y40.81%vs 18.76%+54%
VEEV leads on
- Debt / Equity0.0xvs 1.4x+99%
- P/E (TTM)28.7xvs 36.6x+22%
- EV/EBIT26.9xvs 34.1x+21%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.